title: Once-weekly glucagon-like peptide 1 receptor agonists.
abstract: The once-weekly glucagon-like peptide 1 receptor agonists (QW GLP1RA) represent a major advancement in diabetes pharmaco-therapeutics. This review describes the basic, clinical, and comparative pharmacology of this novel class of drugs. It highlights the clinical placement and posology of these drugs.
authors.affiliation: Department of Endocrinology, Bharti Hospital & BRIDE, Karnal, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
authors.affiliation: Department of Medicine, Government Medical College and Hospital, Chandigarh, India.
authors.forename: Yashdeep
authors.initials: Y
authors.lastname: Gupta
mesh_terms: D003692:Delayed-Action Preparations; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004334:Drug Administration Schedule; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000031:analogs & derivatives; D004763:Glucagon-Like Peptides / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007141:Immunoglobulin Fc Fragments / Q000008:administration & dosage; D054795:Incretins / Q000008:administration & dosage*; D010455:Peptides / Q000008:administration & dosage; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D014688:Venoms / Q000008:administration & dosage; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D007141:Immunoglobulin Fc Fragments; D054795:Incretins; D010455:Peptides; D011993:Recombinant Fusion Proteins; D014688:Venoms; C534611:rGLP-1 protein; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide; C555680:dulaglutide; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
keywords: Albiglutide, dulaglutide, exenatide QW, semaglutide.